Global Research Initiative for Patients Screening on MASH

Inclusion Criteria: * Newly diagnosed subjects should fulfil criteria for diagnosis of type 2 diabetes mellitus or metabolic syndrome or obesity or arterial hypertension, following the study definitions. * Subjects that are currently being treated for type 2 diabetes mellitus or metabolic syndrome or obesity or arterial hypertension, should have had a prior diagnosis based on study definitions. Study definitions: Type 2 diabetes mellitus * At least 2 times a fasting glucose \> 7,0 mmol/L * Or elevated non-fasting glucose \>11,1 mmol/L 2 hrs after OGTT * Or HbA1c ≥48 mmol/mol (≥6.5%) * Or being actively treated for previously diagnosed type 2 diabetes by a health care provider Obesity * Body mass index (BMI) \> 30 * Or waist circumferences Caucasian: male ≥ 94 cm, female ≥ 80 cm South-Asian/Chinese: male ≥90 cm, female ≥80 cm Japanese: male ≥85 cm, female ≥90 cm Arterial hypertension * Systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg * Or being actively treated for previously diagnosed arterial hypertension by a health care provider Metabolic syndrome \- Central obesity defined as waist circumference (see above), if BMI is \>30 kg/m2, central obesity can be assumed and waist circumference does not need to be measured AND any two of the following: * Raised triglycerides: ≥ 150 mg/dL (1.7 mmol/L), or specific treatment for this lipid abnormality * Reduced HDL cholesterol: \< 40 mg/dL (1.03 mmol/L) in males, \< 50 mg/dL (1.29 mmol/L) in females, or specific treatm…